Literature DB >> 15669012

Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions.

Anniek Corveleyn1, Hilde Janssen, Alessandra Martini, Riet Somers, Jan Cools, Peter Marynen.   

Abstract

Molecular cloning of the translocations t(12;22)(p13;q12) and t(12;17)(p13;q11) in acute leukaemia showed that either EWSR1 or its homologue TAF15 are fused to the transcription factor CIZ. EWSR1 and TAF15 belong to the TET family (TLS/FUS, EWSR1 and TAF15) of proteins. TET fusions have been identified in both solid tumours and acute myeloid leukaemia. The novel 12p translocations directly implicated TET fusions in acute lymphoblastic leukaemia as well, and demonstrated the involvement of CIZ in haematopoietic malignancies. In addition, a new fusion E2A-CIZ was recently cloned as a result of a t(12;19)(p13;p13) in a patient with acute lymphoblastic leukaemia. NIH3T3 cells stably expressing TET-CIZ fusions display a transformed phenotype in a focus formation assay. We show here that E2A-CIZ also transforms 3T3 fibroblasts, suggesting that the addition of a transactivation domain to the CIZ protein is involved in this phenotype. An artificial VP16-CIZ construct reveals similar transforming properties, supporting this. We have then analysed the domains within TAF15-CIZ that are necessary for 3T3 fibroblast transformation. Deletion of the zinc fingers of CIZ resulted in loss of both DNA-binding and transforming properties of TAF15-CIZ, whereas deletion of the other functional domains of CIZ had no effect. Fusion of a transactivation domain to CIZ is suggestive for a transactivating function in transformation. Luciferase experiments indeed showed that E2A-CIZ as well as VP16-CIZ transactivates the MMP7 promoter. Taken together, our results reported here suggest that transformation of 3T3 fibroblasts by CIZ fusions is dependent on DNA-binding and might involve transactivation of CIZ target genes. Copyright (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15669012     DOI: 10.1002/jcb.20369

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Authors:  Shinsuke Hirabayashi; Kentaro Ohki; Kazuhiko Nakabayashi; Hitoshi Ichikawa; Yukihide Momozawa; Kohji Okamura; Akinori Yaguchi; Kazuki Terada; Yuya Saito; Ai Yoshimi; Hiroko Ogata-Kawata; Hiromi Sakamoto; Motohiro Kato; Junya Fujimura; Moeko Hino; Akitoshi Kinoshita; Harumi Kakuda; Hidemitsu Kurosawa; Keisuke Kato; Ryosuke Kajiwara; Koichi Moriwaki; Tsuyoshi Morimoto; Kozue Nakamura; Yasushi Noguchi; Tomoo Osumi; Kazuo Sakashita; Junko Takita; Yuki Yuza; Koich Matsuda; Teruhiko Yoshida; Kenji Matsumoto; Kenichiro Hata; Michiaki Kubo; Yoichi Matsubara; Takashi Fukushima; Katsuyoshi Koh; Atsushi Manabe; Akira Ohara; Nobutaka Kiyokawa
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

2.  Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Authors:  Takahiko Yasuda; Shinobu Tsuzuki; Masahito Kawazu; Fumihiko Hayakawa; Shinya Kojima; Toshihide Ueno; Naoto Imoto; Shinji Kohsaka; Akiko Kunita; Koichiro Doi; Toru Sakura; Toshiaki Yujiri; Eisei Kondo; Katsumichi Fujimaki; Yasunori Ueda; Yasutaka Aoyama; Shigeki Ohtake; Junko Takita; Eirin Sai; Masafumi Taniwaki; Mineo Kurokawa; Shinichi Morishita; Masashi Fukayama; Hitoshi Kiyoi; Yasushi Miyazaki; Tomoki Naoe; Hiroyuki Mano
Journal:  Nat Genet       Date:  2016-03-28       Impact factor: 38.330

3.  EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.

Authors:  Akinori Yaguchi; Takeshi Ishibashi; Kazuki Terada; Hitomi Ueno-Yokohata; Yuya Saito; Junya Fujimura; Toshiaki Shimizu; Kentaro Ohki; Atsushi Manabe; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2017-04-04       Impact factor: 2.490

4.  ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.

Authors:  Kirsten M Dickerson; Chunxu Qu; Qingsong Gao; Ilaria Iacobucci; Zhaohui Gu; Hiroki Yoshihara; Emily A Backhaus; Yunchao Chang; Laura J Janke; Beisi Xu; Gang Wu; Evangelia K Papachristou; Clive S D'Santos; Kathryn G Roberts; Charles G Mullighan
Journal:  Blood Cancer Discov       Date:  2022-05-05

5.  Leukemia With TCF3-ZNF384 Rearrangement as a Distinct Subtype of Disease With Distinct Treatments: Perspectives From A Case Report and Literature Review.

Authors:  Na Lin; Xiaojing Yan; Dali Cai; Lei Wang
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.